The benefits of a novel vaccine based on an allogeneic plasmacytoid DC cell line have been explored. In recent years, immunotherapy has finally found its place in the anti-cancer therapeutic arsenal, even becoming standard of care as first line treatment for metastatic forms. However, too many patients remain refractory to these treatments due to weak… Read More »